Approvals/CIMA-AEMPS/CABAZITAXEL FRESENIUS KABI 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

CABAZITAXEL FRESENIUS KABI 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Fresenius Kabi España, S.A.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: de7a28f7290a6363
Drug Cima Aemps Name: CABAZITAXEL FRESENIUS KABI 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 88251
Holder Company Name: Fresenius Kabi España, S.A.U.
Marketing Company Name: Fresenius Kabi España, S.A.U.
Authorization Date: 2022-11-03
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 20 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Fresenius Kabi España, S.A.U.

CABAZITAXEL

20 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 3, 2022

Approval ID

de7a28f7290a6363

Type

Standard